Skip to content

The Epidemiology of TST Change in Korea

The Trend of Tuberculin Skin Test in Korea

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01850043
Enrollment
5552
Registered
2013-05-09
Start date
2005-05-31
Completion date
2012-05-31
Last updated
2013-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Latent Tuberculosis, Tuberculosis

Brief summary

TST will be analyzed in young general population in Korea. Young adults undertake TST as CDC recommendation. Participants with chest radiograph showing active TB lesion are excluded from this study.

Detailed description

Enroll criteria * A term of whole military conscripts per year in one Reserve Force Battalion * Military conscripts gather from all around area in Korea randomly * Each participant undertake a chest X-ray (CXR) and blood tests including human immunodeficiency virus (HIV) at the start of initiatory training. Exclusion Criteria * Chest X-ray suggesting active TB * HIV positive in serology Design * After giving informed consent, all participants receive one-step TST following standard procedures. * The largest transverse diameter of induration is measured 48-72hr after injection. * The investigator and these trained nurses were blinded to the status of their demographic characteristics.

Interventions

None listed

Sponsors

Asan Medical Center
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to 29 Years
Healthy volunteers
Yes

Inclusion criteria

* Military Conscripts age 18-29 years old

Exclusion criteria

* Chest X-ray suggests active TB * Positive HIV in serology

Design outcomes

Primary

MeasureTime frameDescription
TST positivity TST rateTwo days after tuberculin injectionInvestigators measure induration size of tuberculin skin test 48 after tuberculin injection.

Secondary

MeasureTime frame
BCG scar ratesThe day of tuberculin injection

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026